triazoles has been researched along with Hodgkin Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barg, AA; Bartuv, M; Greenberg, G; Keller, N; Malkiel, S; Toren, A | 1 |
Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
Assanelli, A; Barbanti, MC; Bernardi, M; Carrabba, M; Ciceri, F; Corti, C; Forcina, A; Giglio, F; Greco, R; Lupo Stranghellini, MT; Marktel, S; Messina, C; Morelli, M; Oltolini, C; Peccatori, J; Piemontese, S; Scarpellini, P; Vago, L | 1 |
Argueta, C; Bastard, C; Bertrand, P; Bohers, E; Camus, V; Copie-Bergman, C; Cornic, M; Damotte, D; Delarue, R; Dubois, S; Dyer, MJ; Fest, T; Figeac, M; Gaulard, P; Haioun, C; Jais, JP; Jardin, F; Landesman, Y; Lemasle, E; Lemonnier, F; Leroy, K; Maingonnat, C; Mareschal, S; Milpied, N; Moeller, P; Molina, TJ; Ochmann, M; Pelletier, L; Picquenot, JM; Pujals, A; Salles, G; Sola, B; Stamatoullas, A; Sundstrom, C; Tilly, H; Traverse-Glehen, A; Viailly, PJ | 1 |
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K | 1 |
1 trial(s) available for triazoles and Hodgkin Disease
5 other study(ies) available for triazoles and Hodgkin Disease
Article | Year |
---|---|
Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child, Preschool; Female; Hodgkin Disease; Humans; Immunocompromised Host; Male; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles | 2018 |
Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Risk; Sirolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult | 2016 |
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
Topics: Acrylates; Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Biomarkers; Cell Line, Tumor; Exportin 1 Protein; Female; Gene Expression Profiling; Hodgkin Disease; Humans; Hydrazines; Karyopherins; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Mutation; Receptors, Cytoplasmic and Nuclear; Sequence Analysis, DNA; Triazoles; Young Adult | 2016 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole | 2006 |